HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 315 filers reported holding HALOZYME THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 0.92 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $1,044,343 | -15.0% | 18,354 | -40.9% | 0.01% | -16.7% |
Q3 2022 | $1,228,000 | -72.3% | 31,051 | -69.2% | 0.01% | -68.4% |
Q2 2022 | $4,432,000 | +65.2% | 100,724 | +56.5% | 0.02% | +26.7% |
Q1 2021 | $2,683,000 | -46.6% | 64,359 | -45.3% | 0.02% | -48.3% |
Q4 2020 | $5,028,000 | +99.0% | 117,716 | +22.4% | 0.03% | +81.2% |
Q3 2020 | $2,527,000 | +101.7% | 96,171 | +105.9% | 0.02% | +77.8% |
Q2 2020 | $1,253,000 | – | 46,703 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Third Security, LLC | 7,048,282 | $126,799,000 | 27.23% |
First Light Asset Management, LLC | 1,630,591 | $29,334,000 | 5.01% |
SNYDER CAPITAL MANAGEMENT L P | 3,393,057 | $61,041,000 | 3.48% |
Bellevue Group AG | 7,663,956 | $137,874,000 | 2.67% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 307,633 | $5,531,000 | 2.52% |
Lombard Odier Asset Management (Switzerland) SA | 900,000 | $16,191,000 | 2.17% |
Elk Creek Partners, LLC | 654,362 | $11,772,000 | 2.02% |
DOHENY ASSET MANAGEMENT /CA | 127,110 | $2,254,000 | 1.79% |
Granite Investment Partners, LLC | 1,277,438 | $22,981,000 | 1.49% |
Amia Capital LLP | 69,409 | $1,249,000 | 1.11% |